XM does not provide services to residents of the United States of America.

South African rand firms at start of data-packed week



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-South African rand firms at start of data-packed week</title></head><body>

Updates prices, adds analyst comment in paragraphs 4-5

JOHANNESBURG, Aug 12 (Reuters) -The South African rand was stronger on Monday at the start of a week filled with closely watched global and domestic economic data releases.

At 1517 GMT, the rand traded at 18.20 against the dollar ZAR=D3, about 0.7% firmer than its previous closing level.

The U.S. dollar =USD was down about 0.1% against a basket of global currencies.

"Currency markets have continued to drift sideways in anticipation of the data-filled week," said Wichard Cilliers, head of market risk at TreasuryONE.

"Emerging market currencies have firmed further after last week's sell-off, with the rand trading back at the R18.20 handle," Cilliers added.

The rand is likely to take its direction this week from global data prints including U.S. consumer inflation data on Wednesday, and South African mining ZAMNG=ECI, unemployment ZAUNR=ECI and retail sales ZARET=ECI figures over Tuesday and Wednesday.

The U.S. inflation reading will be scrutinised for clues on the Federal Reserve's monetary policy path, while the local data releases will show whether Africa's most industrialised economy gained any momentum in the middle of the year.

Oxford Economics Africa said the domestic data releases were not expected to show much improvement, with the unemployment rate seen stuck around 32%, the mining sector dealing with supply-side constraints and subdued consumer demand continuing to pressure retail.

On the Johannesburg Stock Exchange, the blue-chip Top-40 index .JTOPI closed about 0.1% down. South Africa's benchmark 2030 government bond ZAR2030= was stronger, with the yield down 3 basis points at 9.36%.



Reporting by Alexander Winning and Tannur Anders; Editing by Shounak Dasgupta and Susan Fenton

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.